𝔖 Bobbio Scriptorium
✦   LIBER   ✦

P148 Surgical treatment of patients with multiple myeloma involving the spine: retrospective analysis

✍ Scribed by L. Danka; P.P. Varga


Publisher
Elsevier Science
Year
2007
Tongue
English
Weight
66 KB
Volume
21
Category
Article
ISSN
0268-960X

No coin nor oath required. For personal study only.


πŸ“œ SIMILAR VOLUMES


The use of low-dose prednisone and melph
✍ Cuttner, Janet ;Wasserman, L. R. ;Martz, Georg ;Sonntag, Roland W. ;Kyle, Robert πŸ“‚ Article πŸ“… 1975 πŸ› John Wiley and Sons 🌐 English βš– 416 KB

## Abstract A study was designed to evaluate the effectiveness of prednisone therapy in poor‐risk patients with multiple myeloma. Patients were treated with melphalan alone or in combination with prednisone at doses of either 0.6 mg/kg or 0.3 mg/ kg. The group of patients receiving melphalan and pr

Quality of life in patients with multipl
✍ Ladislav Slovacek; Birgita Slovackova; Martin Blazek; Ladislav Jebavy πŸ“‚ Article πŸ“… 2007 πŸ› Wielkopolskie Centrum Onkologii 🌐 Polish βš– 109 KB

## Background Quality of life (QoL) is defi ned as "a patient's subjective evaluation of his life situation". QoL evaluation is carried out by means of generic and specifi c questionnaires. Generic QoL questionnaires generally evaluate a patient's overall condition regardless of his disease. Speci

Weekly treatment with bortezomib for pat
✍ John D. Hainsworth; David R. Spigel; John Barton; Cindy Farley; Marshall Schreed πŸ“‚ Article πŸ“… 2008 πŸ› John Wiley and Sons 🌐 English βš– 134 KB πŸ‘ 2 views

## Abstract ## BACKGROUND. The purpose of the current study was to evaluate the efficacy and toxicity of weekly bortezomib in the treatment of patients with recurrent/refractory multiple myeloma. ## METHODS. A total of 40 patients with multiple myeloma who had received either 1 or 2 previous tre

Peripheral blood stem cell collection in
✍ Paola Coluccia; Vittorio Montefusco; Sara Tunesi; Mario Avella; Alvaro Bompadre; πŸ“‚ Article πŸ“… 2009 πŸ› John Wiley and Sons 🌐 English βš– 104 KB

Double autologous stem cell transplantation is the standard treatment in newly diagnosed multiple myeloma (MM) patients younger than 65 years; therefore, optimization of leukapheresis is crucial. We performed a retrospective analysis of 297 leukaphereses comparing semiautomated (V4.7 in 20% of colle